ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 40863356

Fibroblast Growth Factor 23 Is a Strong Predictor of Adverse Events After Left Ventricular Assist Device Implantation.

Yared W and 10 others. J Cardiovasc Dev Dis, 2025. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Fibroblast Growth Factor 23 Is a Strong Predictor of Adverse Events After Left Ventricular Assist Device Implantation. Papers, record 40863356. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40863356

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fibroblast Growth Factor 23 Is a Strong Predictor of Adverse Events After Left Ventricular Assist Device Implantation.
PubMed
Journal
J Cardiovasc Dev Dis
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-09-14
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yared WWissam
2Dogan LLeyla
3Fassli AMAhsannullah Madad
4Moza AAjay
5Goetzenich AAndreas
6Stoppe CChristianhttps://orcid.org/0000-0002-2028-2039
7Mohammed AFAAhmed F A
8Kraemer SSandrahttps://orcid.org/0000-0002-2958-843X
9Tewarie LLachmandath
10Abugameh AAhmad

1 to 10 of 11Source PubMed

See all 11 authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111,276,432Fibroblast growth factors.Genome Biol2001https://conductscience.org/library/papers/11276432PubMed
222,378,855EuroSCORE II.Eur J Cardiothorac Surg2012https://conductscience.org/library/papers/22378855PubMed
323,791,165Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era.Ann Thorac Surg2013https://conductscience.org/library/papers/23791165PubMed
434,556,489A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease.J Am Soc Nephrol2021https://conductscience.org/library/papers/34556489PubMed
529,306,478Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure.Int J Cardiol2018https://conductscience.org/library/papers/29306478PubMed
619,063,940The Klotho gene family as a regulator of endocrine fibroblast growth factors.Mol Cell Endocrinol2009https://conductscience.org/library/papers/19063940PubMed
726,757,465Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.JAMA2016https://conductscience.org/library/papers/26757465PubMed
833,767,635An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk.Front Physiol2021https://conductscience.org/library/papers/33767635PubMed
929,710,336Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.JAMA Cardiol2018https://conductscience.org/library/papers/29710336PubMed
1035,007,505Twelfth Interagency Registry for Mechanically Assisted Circulatory Support Report: Readmissions After Left Ventricular Assist Device.Ann Thorac Surg2022https://conductscience.org/library/papers/35007505PubMed

1 to 10 of 34

See all 34 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

None in this release.

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FGF238,074PubTator's text mininghttps://conductscience.org/library/genes/8074NCBI Gene
GPT2,875PubTator's text mininghttps://conductscience.org/library/genes/2875NCBI Gene
KL9,365PubTator's text mininghttps://conductscience.org/library/genes/9365NCBI Gene
PTH5,741PubTator's text mininghttps://conductscience.org/library/genes/5741NCBI Gene
REN5,972PubTator's text mininghttps://conductscience.org/library/genes/5972NCBI Gene
SLC17A526,503PubTator's text mininghttps://conductscience.org/library/genes/26503NCBI Gene
TXK7,294PubTator's text mininghttps://conductscience.org/library/genes/7294NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40863356

GET https://conductscience.org/api/papers/v1/40863356/references?page=2

API referenceFor AI assistants